You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The number of technologies to be assessed is vast, and ranges from liquid biopsies and molecular imaging to immunohistochemistry and RNA-seq.
CRUK will invest £40 million over the next five years to support the alliance, while US partners will invest $20 million to support research projects and infrastructure.
The deals cover Plexbio's IntelliPlex 1000 πCode Processor and the PlexBio 100 Fluorescent Analyzer for the IVD and life science research markets.
The financing follows a $5.15 million Series A round completed in 2015 and will go toward development and commercialization of Ultivue's InSituPlex technology.
Researchers at Tufts and their collaborators recently demonstrated that the approach, which uses multiphoton microscopy, can distinguish between normal and cancerous skin.